Slattery Martha L, Lundgreen Abbie, Mullany Lila E, Penney Rosalind B, Wolff Roger K
Department of Internal Medicine, University of Utah Health Sciences Center Salt Lake City, UT 84018, USA.
Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences Little Rock, Arkansas, USA.
Int J Mol Epidemiol Genet. 2014 May 29;5(2):100-11. eCollection 2014.
Candidate pathway approaches in disease association studies often utilize a tagSNP approach to capture genetic variation. In this paper we assess gene expression patterns with SNPs in genes in the CHIEF pathway to help determine their potential functionality.
Quantitative real-time RT-PCR was run to determine gene expression of 13 genes in normal colon tissue samples from 82 individuals. TagSNP genotype data were obtained from a GoldenGate Illumina multiplex bead array platform. Age, sex, and genetic ancestry adjusted general linear models were used to estimate beta coefficients and p values.
Genetic variation in mTOR (1 SNP), NFKB1 (4 SNPs), PRKAG2 (3 SNPs), and TSC2 (1 SNP) significantly influenced their expression. After adjustment for multiple comparisons several associations between pathway genes and expression of other genes were significant. These included AKT1 rs1130214 associated with expression of PDK1; NFκB1 rs13117745 and rs4648110 with STK11 expression; PRKAG2 rs6965771 with expression of NFκB1, PIK3CA, and RPS6KB2; RPS6KB1 rs80711475 with STK11 expression; STK11 rs741765 with PIK3CA and PRKAG2 expression; and TSC2 rs3087631 with AKT1, IkBκB, NFκB1, PDK1, PIK3CA, PRKAG2, and PTEN expression. The higher levels of differential expression were noted for TSC2 rs3087631 (percent difference ranges from 108% to 198% across genes). Many of these SNPs and genes also were associated with colon and rectal cancer risk.
Our results suggest that pathway genes may regulate expression of other genes in the pathway. The convergence of these genes in several biological pathways involved in cancer further supports their importance to the carcinogenic process.
疾病关联研究中的候选通路方法通常采用标签单核苷酸多态性(tagSNP)方法来捕捉遗传变异。在本文中,我们评估了CHIEF通路中基因的单核苷酸多态性与基因表达模式,以帮助确定它们的潜在功能。
运用定量实时逆转录聚合酶链反应(RT-PCR)来测定82名个体正常结肠组织样本中13个基因的表达。标签单核苷酸多态性基因型数据来自Illumina GoldenGate多重微珠阵列平台。使用年龄、性别和遗传血统调整后的一般线性模型来估计β系数和p值。
雷帕霉素靶蛋白(mTOR,1个单核苷酸多态性)、核因子κB1(NFKB1,4个单核苷酸多态性)、蛋白激酶Aγ2调节亚基(PRKAG2,3个单核苷酸多态性)和结节性硬化症复合物2(TSC2,1个单核苷酸多态性)的遗传变异显著影响它们的表达。在对多重比较进行校正后,通路基因与其他基因表达之间的几种关联具有显著性。这些关联包括:与磷酸肌醇依赖性蛋白激酶1(PDK1)表达相关的蛋白激酶B1(AKT1)rs1130214;与丝氨酸/苏氨酸蛋白激酶11(STK11)表达相关的核因子κB1 rs13117745和rs4648110;与核因子κB1、磷脂酰肌醇-3激酶催化亚基α(PIK3CA)和核糖体蛋白S6激酶β2(RPS6KB2)表达相关的蛋白激酶Aγ2调节亚基rs6965771;与丝氨酸/苏氨酸蛋白激酶11表达相关的核糖体蛋白S6激酶β1(RPS6KB1)rs80711475;与磷脂酰肌醇-3激酶催化亚基α和蛋白激酶Aγ2调节亚基表达相关的丝氨酸/苏氨酸蛋白激酶11 rs741765;以及与蛋白激酶B1、核因子κB抑制蛋白κB(IkBκB)、核因子κB1、磷酸肌醇依赖性蛋白激酶1、磷脂酰肌醇-3激酶催化亚基α、蛋白激酶Aγ2调节亚基和磷酸酶及张力蛋白同源物(PTEN)表达相关的结节性硬化症复合物2 rs3087631。结节性硬化症复合物2 rs3087631的差异表达水平更高(各基因的差异百分比范围为108%至198%)。这些单核苷酸多态性和基因中的许多也与结肠癌和直肠癌风险相关。
我们的结果表明,通路基因可能调节通路中其他基因的表达。这些基因在几个与癌症相关的生物通路中的汇聚进一步支持了它们在致癌过程中的重要性。